Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.

There are 1,580 beds in Sheba Medical Center - National Hemophilia Center.

During the past decade, Sheba Medical Center - National Hemophilia Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sheba Medical Center - National Hemophilia Center" are "Hemophilia A" (1 trials) and "Severe Hemophilia A" (1 trials). Many other conditions were trialed in "Sheba Medical Center - National Hemophilia Center" in a lesser frequency.

Most popular intervention types in "Sheba Medical Center - National Hemophilia Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sheba Medical Center - National Hemophilia Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sheba Medical Center - National Hemophilia Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sheba Medical Center - National Hemophilia Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sheba Medical Center - National Hemophilia Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".